The Europe stem cell market is predicted to rise with a CAGR of 8.60% across the forecast years of 2022 to 2030, acquiring a revenue share of $4784.66 million by 2030.
EUROPE STEM CELL MARKET FORECAST 2022-2030
Europe Stem Cell Market by Therapeutic Application (Orthopedic Treatments, Injuries & Wounds, Oncology Disorders, Cardiovascular Disorders, Neurological Disorders, Diabetes, Other Therapeutic Applications) Market by Product (Adult Stem Cell, Human Embryonic Stem Cell, Pluripotent, Mouse/Rat Neural) Market by Technology (Cell Acquisition, Cell Production, Cryopreservation, Expansion & Sub-culture) By Geography
The Europe stem cell market is predicted to rise with a CAGR of 8.60% across the forecast years of 2022 to 2030, acquiring a revenue share of $4784.66 million by 2030.
The market growth of the region is propelled by the surging prevalence of target conditions, the rise in product releases, the growing awareness about stem cell-based therapies for numerous skin and hair disorders, as well as strategic initiatives, such as collaborations and agreements. However, the Europe stem cell market is likely to be challenged by fragmented cross-border supply chains and the lack of manufacturing capacity.
To know more about this report, request a free sample copy
The Europe stem cell market growth assessment includes the study of the United Kingdom, France, Belgium, Germany, Poland, Italy, and Rest of Europe. In 2019, as per the National Health Service (NHS), more than 327,170 cases of cancer were diagnosed in the United Kingdom. Likewise, according to Nomis, a service offered by the Office for National Statistics (ONS), 137,234 cancer fatalities were reported in the country. Some of the most common types of cancer detected in the United Kingdom include breast, prostate, lung, skin, and colon cancers. Furthermore, according to the National Clinical Trial Registry (NCT), around 103 clinical trials related to stem cell therapy were registered as of June 2020 across different phases of development. If these trials yield positive results, new stem cell therapies will likely be implemented in the United Kingdom for treating various conditions in the future.
As per the German Alzheimer Society, Germany has more than 1.6 million people suffering from dementia, with around 300,000 new cases identified annually. The analysis also states that by 2050, as a result of an aging populace and shifting demographics, up to 2.8 million individuals are estimated to be affected by the condition. Furthermore, with the surging incidence rate of neurological dementia in Germany, market players are focused on the development of new and effective stem cell therapies. Therefore, the above-mentioned factors are expected to provide the stem cell market in Europe with significant growth opportunities during the forecast period.
The Europe stem cell market is segmented into therapeutic application, product, technology, application, and treatment type. The product segment comprises adult stem cell, human embryonic cell, pluripotent, and mouse/rat neural. Adult stem cells are characterized as undifferentiated stem cells found in the tissues of adult humans. Adult stem cells, upon maturity, can morph into different cell types with distinct shapes and functionality.
The research based on adult stem cells is facilitated by their capability to self-renew or divide indefinitely, subsequently generating all cell types of the organ of origin — potentially regenerating the entire organ from a limited number of cells.
Key companies operating in the Europe stem cell market are Merck KGaA (Sigma Aldrich), Smith+Nephew PLC, Qiagen, etc.
Smith+Nephew PLC, headquartered in Germany, manufactures and develops endoscopy, orthopedic reconstruction, trauma, and advanced wound management equipment for hospitals and hospitals. It also provides products for access/fluid management, deformity correction, burns, grafts/dermal substitutes, computer-assisted surgery, fracture management, joint repair and joint replacement, diabetic foot ulcers, and others.
The company’s Stravix is a cryopreserved placental tissue utilized as a surgical wrap or cover. It supports soft tissue repair in various surgical procedures.
Report Synopsis
| Report Scope | Details |
| Market Forecast Years | 2022-2030 |
| Base Year | 2021 |
| Market Historical Years | 2018-2021 |
| Forecast Units | Revenue ($ Million) |
| Segments Analyzed | Therapeutic Application, Product, Technology, Application, Treatment Type |
| Countries Analyzed | The United Kingdom, France, Belgium, Germany, Poland, Italy, and Rest of Europe. |
| Companies Analyzed | AllCells LLC, Becton, Dickinson and Company, Corning Inc, Lorem Cytori Inc, GE Healthcare, International Stem Cell Corporation (ISCO), Merck KGaA (Sigma Aldrich), Miltenyi Biotec, Pluri Inc, Qiagen, Smith+Nephew PLC, Stemcell Technologies Inc, Stryker Corporation, Takara Holdings Inc, Thermo Fisher Scientific Inc |
To request a free sample copy of this report, please complete the form below:
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.
- RESEARCH SCOPE & METHODOLOGY
- STUDY OBJECTIVES
- SCOPE OF STUDY
- METHODOLOGY
- ASSUMPTIONS & LIMITATIONS
- EXECUTIVE SUMMARY
- MARKET SIZE & ESTIMATES
- MARKET OVERVIEW
- MARKET DYNAMICS
- KEY DRIVERS
- SURGING DEMAND FOR STEM CELLS IN REGENERATIVE MEDICINE
- GROWING R&D INVESTMENTS IN STEM CELL THERAPIES & RESEARCH
- RISING AWARENESS ABOUT UMBILICAL CORD STEM CELLS
- REDUCED RISK OF TISSUE REJECTION IN TRANSPLANTS
- KEY RESTRAINTS
- ABSENCE OF A WELL-DEFINED REGULATORY FRAMEWORK FOR STEM CELL THERAPY
- HIGH COSTS ASSOCIATED WITH STEM CELL PROCEDURES
- ETHICAL ISSUES AND SOCIAL COMPLEXITIES
- LESS RESPONSIVENESS IN DEVELOPED ECONOMIES
- KEY DRIVERS
- KEY ANALYTICS
- IMPACT OF COVID-19 ON STEM CELL MARKET
- KEY MARKET TRENDS
- PORTER’S FIVE FORCES ANALYSIS
- BUYERS POWER
- SUPPLIERS POWER
- SUBSTITUTION
- NEW ENTRANTS
- INDUSTRY RIVALRY
- OPPORTUNITY MATRIX
- VENDOR LANDSCAPE
- VALUE CHAIN ANALYSIS
- KEY BUYING CRITERIA
- PRICE
- EFFICACY
- APPLICATION AND EFFECTIVENESS
- ACCURACY
- REGULATORY FRAMEWORK
- MARKET BY THERAPEUTIC APPLICATION
- ORTHOPEDIC TREATMENTS
- INJURIES & WOUNDS
- ONCOLOGY DISORDERS
- CARDIOVASCULAR DISORDERS
- NEUROLOGICAL DISORDERS
- DIABETES
- OTHER THERAPEUTIC APPLICATIONS
- MARKET BY PRODUCT
- ADULT STEM CELL
- HEMATOPOIETIC STEM CELL
- NEURAL STEM CELL
- UMBILICAL CORD STEM CELL
- MESENCHYMAL STEM CELL
- DENTAL STEM CELL
- HUMAN EMBRYONIC STEM CELL
- PLURIPOTENT
- MOUSE/RAT NEURAL
- ADULT STEM CELL
- MARKET BY TECHNOLOGY
- CELL ACQUISITION
- BONE MARROW HARVEST
- UMBILICAL CORD
- APHERESIS
- CELL PRODUCTION
- THERAPEUTIC CLONING
- IN VITRO FERTILIZATION (IVF)
- CELL CULTURE
- ISOLATION
- CRYOPRESERVATION
- EXPANSION & SUB-CULTURE
- CELL ACQUISITION
- MARKET BY APPLICATION
- REGENERATIVE MEDICINE
- DRUG DISCOVERY AND DEVELOPMENT
- MARKET BY TREATMENT TYPE
- ALLOGENEIC STEM CELL THERAPY
- AUTOLOGIC STEM CELL THERAPY
- SYNGENEIC STEM CELL THERAPY
- GEOGRAPHICAL ANALYSIS
- EUROPE
- MARKET SIZE & ESTIMATES
- KEY GROWTH ENABLERS
- KEY CHALLENGES
- KEY PLAYERS
- COUNTRY ANALYSIS
- UNITED KINGDOM
- GERMANY
- FRANCE
- ITALY
- BELGIUM
- POLAND
- REST OF EUROPE
- EUROPE
- COMPETITIVE LANDSCAPE
- KEY STRATEGIC DEVELOPMENTS
- ACQUISITIONS
- PARTNERSHIPS
- COMPANY PROFILES
- ALLCELLS LLC
- BECTON, DICKINSON AND COMPANY (BD)
- CORNING INC
- GE HEALTHCARE
- INTERNATIONAL STEM CELL CORPORATION
- LOREM CYTORI INC
- MERCK KGAA (SIGMA ALDRICH)
- MILTENYI BIOTEC
- PLURI INC
- QIAGEN
- SMITH+NEPHEW PLC
- STEMCELL TECHNOLOGIES INC
- STRYKER CORPORATION
- TAKARA HOLDINGS INC
- THERMO FISHER SCIENTIFIC INC
- KEY STRATEGIC DEVELOPMENTS
LIST OF TABLES
TABLE 1: EUROPE MARKET SNAPSHOT – STEM CELL
TABLE 2: EXAMPLES OF APPROVED CELL THERAPY PRODUCTS
TABLE 3: REGULATORY FRAMEWORK
TABLE 4: EUROPE STEM CELL MARKET, BY THERAPEUTIC APPLICATION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 5: EUROPE STEM CELL MARKET, BY THERAPEUTIC APPLICATION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 6: EUROPE STEM CELL MARKET, BY PRODUCT, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 7: EUROPE STEM CELL MARKET, BY PRODUCT, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 8: EUROPE STEM CELL MARKET, BY ADULT STEM CELL, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 9: EUROPE STEM CELL MARKET, BY ADULT STEM CELL, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 10: EUROPE STEM CELL MARKET, BY TECHNOLOGY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 11: EUROPE STEM CELL MARKET, BY TECHNOLOGY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 12: EUROPE STEM CELL MARKET, BY CELL ACQUISITION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 13: EUROPE STEM CELL MARKET, BY CELL ACQUISITION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 14: EUROPE STEM CELL MARKET, BY CELL PRODUCTION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 15: EUROPE STEM CELL MARKET, BY CELL PRODUCTION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 16: EUROPE STEM CELL MARKET, BY APPLICATION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 17: EUROPE STEM CELL MARKET, BY APPLICATION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 18: EUROPE STEM CELL MARKET, BY TREATMENT TYPE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 19: EUROPE STEM CELL MARKET, BY TREATMENT TYPE, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 20: EUROPE STEM CELL MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 21: EUROPE STEM CELL MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 22: LEADING PLAYERS OPERATING IN EUROPE STEM CELL MARKET
TABLE 23: LIST OF ACQUISITIONS
TABLE 24: LIST OF PARTNERSHIPS
LIST OF FIGURES
FIGURE 1: KEY MARKET TRENDS
FIGURE 2: STEM CELL SCREENING STRATEGIES AND THEIR POTENTIAL APPLICATION
FIGURE 3: PORTER’S FIVE FORCES ANALYSIS
FIGURE 4: OPPORTUNITY MATRIX
FIGURE 5: VENDOR LANDSCAPE
FIGURE 6: VALUE CHAIN ANALYSIS
FIGURE 7: KEY BUYING CRITERIA
FIGURE 8: EUROPE STEM CELL MARKET, GROWTH POTENTIAL, BY THERAPEUTIC APPLICATION, IN 2021
FIGURE 9: EUROPE STEM CELL MARKET, BY ORTHOPEDIC TREATMENTS, 2022-2030 (IN $ MILLION)
FIGURE 10: EUROPE STEM CELL MARKET, BY INJURIES & WOUNDS, 2022-2030 (IN $ MILLION)
FIGURE 11: EUROPE STEM CELL MARKET, BY ONCOLOGY DISORDERS, 2022-2030 (IN $ MILLION)
FIGURE 12: EUROPE STEM CELL MARKET, BY CARDIOVASCULAR DISORDERS, 2022-2030 (IN $ MILLION)
FIGURE 13: EUROPE STEM CELL MARKET, BY NEUROLOGICAL DISORDERS, 2022-2030 (IN $ MILLION)
FIGURE 14: EUROPE STEM CELL MARKET, BY DIABETES, 2022-2030 (IN $ MILLION)
FIGURE 15: EUROPE STEM CELL MARKET, BY OTHER THERAPEUTIC APPLICATIONS, 2022-2030 (IN $ MILLION)
FIGURE 16: EUROPE STEM CELL MARKET, GROWTH POTENTIAL, BY PRODUCT, IN 2021
FIGURE 17: EUROPE STEM CELL MARKET, BY ADULT STEM CELL MARKET, 2022-2030 (IN $ MILLION)
FIGURE 18: EUROPE STEM CELL MARKET, GROWTH POTENTIAL, BY ADULT STEM CELL, IN 2021
FIGURE 19: EUROPE STEM CELL MARKET, BY HEMATOPOIETIC STEM CELL MARKET, 2022-2030 (IN $ MILLION)
FIGURE 20: EUROPE STEM CELL MARKET, BY NEURAL STEM CELL MARKET, 2022-2030 (IN $ MILLION)
FIGURE 21: EUROPE STEM CELL MARKET, BY UMBILICAL CORD STEM CELL MARKET, 2022-2030 (IN $ MILLION)
FIGURE 22: EUROPE STEM CELL MARKET, BY MESENCHYMAL STEM CELL MARKET, 2022-2030 (IN $ MILLION)
FIGURE 23: EUROPE STEM CELL MARKET, BY DENTAL STEM CELL MARKET, 2022-2030 (IN $ MILLION)
FIGURE 24: EUROPE STEM CELL MARKET, BY HUMAN EMBRYONIC STEM CELL, 2022-2030 (IN $ MILLION)
FIGURE 25: EUROPE STEM CELL MARKET, BY PLURIPOTENT, 2022-2030 (IN $ MILLION)
FIGURE 26: EUROPE STEM CELL MARKET, BY MOUSE/RAT NEURAL, 2022-2030 (IN $ MILLION)
FIGURE 27: EUROPE STEM CELL MARKET, GROWTH POTENTIAL, BY TECHNOLOGY, IN 2021
FIGURE 28: EUROPE STEM CELL MARKET, BY CELL ACQUISITION, 2022-2030 (IN $ MILLION)
FIGURE 29: EUROPE STEM CELL MARKET, GROWTH POTENTIAL, BY CELL ACQUISITION, IN 2021
FIGURE 30: EUROPE STEM CELL MARKET, BY BONE MARROW HARVEST, 2022-2030 (IN $ MILLION)
FIGURE 31: EUROPE STEM CELL MARKET, BY UMBILICAL CORD, 2022-2030 (IN $ MILLION)
FIGURE 32: EUROPE STEM CELL MARKET, BY APHERESIS, 2022-2030 (IN $ MILLION)
FIGURE 33: EUROPE STEM CELL MARKET, BY CELL PRODUCTION, 2022-2030 (IN $ MILLION)
FIGURE 34: EUROPE STEM CELL MARKET, GROWTH POTENTIAL, BY CELL PRODUCTION, IN 2021
FIGURE 35: EUROPE STEM CELL MARKET, BY THERAPEUTIC CLONING, 2022-2030 (IN $ MILLION)
FIGURE 36: EUROPE STEM CELL MARKET, BY IN VITRO FERTILIZATION (IVF), 2022-2030 (IN $ MILLION)
FIGURE 37: EUROPE STEM CELL MARKET, BY CELL CULTURE, 2022-2030 (IN $ MILLION)
FIGURE 38: EUROPE STEM CELL MARKET, BY ISOLATION, 2022-2030 (IN $ MILLION)
FIGURE 39: EUROPE STEM CELL MARKET, BY CRYOPRESERVATION, 2022-2030 (IN $ MILLION)
FIGURE 40: EUROPE STEM CELL MARKET, BY EXPANSION & SUB-CULTURE, 2022-2030 (IN $ MILLION)
FIGURE 41: EUROPE STEM CELL MARKET, GROWTH POTENTIAL, BY APPLICATION, IN 2021
FIGURE 42: EUROPE STEM CELL MARKET, BY REGENERATIVE MEDICINE, 2022-2030 (IN $ MILLION)
FIGURE 43: EUROPE STEM CELL MARKET, BY DRUG DISCOVERY AND DEVELOPMENT, 2022-2030 (IN $ MILLION)
FIGURE 44: EUROPE STEM CELL MARKET, GROWTH POTENTIAL, BY TREATMENT TYPE, IN 2021
FIGURE 45: EUROPE STEM CELL MARKET, BY ALLOGENEIC STEM CELL THERAPY, 2022-2030 (IN $ MILLION)
FIGURE 46: EUROPE STEM CELL MARKET, BY AUTOLOGIC STEM CELL THERAPY, 2022-2030 (IN $ MILLION)
FIGURE 47: EUROPE STEM CELL MARKET, BY SYNGENEIC STEM CELL THERAPY, 2022-2030 (IN $ MILLION)
FIGURE 48: EUROPE STEM CELL MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)
FIGURE 49: UNITED KINGDOM STEM CELL MARKET, 2022-2030 (IN $ MILLION)
FIGURE 50: GERMANY STEM CELL MARKET, 2022-2030 (IN $ MILLION)
FIGURE 51: FRANCE STEM CELL MARKET, 2022-2030 (IN $ MILLION)
FIGURE 52: ITALY STEM CELL MARKET, 2022-2030 (IN $ MILLION)
FIGURE 53: BELGIUM STEM CELL MARKET, 2022-2030 (IN $ MILLION)
FIGURE 54: POLAND STEM CELL MARKET, 2022-2030 (IN $ MILLION)
FIGURE 55: REST OF EUROPE STEM CELL MARKET, 2022-2030 (IN $ MILLION)
- GEOGRAPHICAL ANALYSIS
- EUROPE
- MARKET SIZE & ESTIMATES
- KEY GROWTH ENABLERS
- KEY CHALLENGES
- KEY PLAYERS
- COUNTRY ANALYSIS
- UNITED KINGDOM
- GERMANY
- FRANCE
- ITALY
- BELGIUM
- POLAND
- REST OF EUROPE
- EUROPE
- MARKET BY THERAPEUTIC APPLICATION
- ORTHOPEDIC TREATMENTS
- INJURIES & WOUNDS
- ONCOLOGY DISORDERS
- CARDIOVASCULAR DISORDERS
- NEUROLOGICAL DISORDERS
- DIABETES
- OTHER THERAPEUTIC APPLICATIONS
- MARKET BY PRODUCT
- ADULT STEM CELL
- HEMATOPOIETIC STEM CELL
- NEURAL STEM CELL
- UMBILICAL CORD STEM CELL
- MESENCHYMAL STEM CELL
- DENTAL STEM CELL
- HUMAN EMBRYONIC STEM CELL
- PLURIPOTENT
- MOUSE/RAT NEURAL
- ADULT STEM CELL
- MARKET BY TECHNOLOGY
- CELL ACQUISITION
- BONE MARROW HARVEST
- UMBILICAL CORD
- APHERESIS
- CELL PRODUCTION
- THERAPEUTIC CLONING
- IN VITRO FERTILIZATION (IVF)
- CELL CULTURE
- ISOLATION
- CRYOPRESERVATION
- EXPANSION & SUB-CULTURE
- CELL ACQUISITION
- MARKET BY APPLICATION
- REGENERATIVE MEDICINE
- DRUG DISCOVERY AND DEVELOPMENT
- MARKET BY TREATMENT TYPE
- ALLOGENEIC STEM CELL THERAPY
- AUTOLOGIC STEM CELL THERAPY
- SYNGENEIC STEM CELL THERAPY
To request a free sample copy of this report, please complete the form below :
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.